Natera Executives Engage in Stock Transactions
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Marcus Gail Boxer | Director | Sell | $719,490 | Form 4 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | $500,304 | Form 4 |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell | $889,778 | Form 4 |
Marcus Gail Boxer, a Director at Natera, sold 4,299 shares of Common Stock on July 1, 2025, at weighted average prices of $167.0518 and $167.5554, totaling $719,490. Following the sale, Boxer directly owns 8,118 shares of Natera's Common Stock.
Solomon Moshkevich, President of Clinical Diagnostics at Natera, sold 3,000 shares of common stock on the same date, with sales conducted at weighted average prices between $163.8764 and $167.79, resulting in a total sale amount of $500,304. Post-transaction, Moshkevich directly owns 130,205 shares.
Steven Leonard Chapman, CEO and President of Natera, reported selling 5,343 shares of common stock on July 1, 2025. The transactions were executed at prices ranging from $163.55 to $167.79, under a Rule 10b5-1 trading plan, for a total of $889,778. Chapman's direct ownership following these sales amounts to 173,728 shares of Common Stock and 174,376 shares of Common Stock in Natera.